X
GO
CARPHA’s Caribbean Regulatory System (CRS) Recommends Its First COVID-19 PCR Test Kit for Pandemic Use to CARICOM  /

CARPHA’s Caribbean Regulatory System (CRS) Recommends Its First COVID-19 PCR Test Kit for Pandemic Use to CARICOM /

Port of Spain, Trinidad and Tobago. 22 July 2020. The Caribbean Public Health Agency's Caribbean Regulatory System (CARPHA - CRS) has issued the first ever recommendation of a diagnostic test kit for the novel SARS-CoV-2 coronavirus 2019 for emergency use authorisation and/or import by CARICOM Member States during the current pandemic.  Based on guidance developed by the Pan American Health Organization (PAHO)[1], the CARPHA-CRS implemented a verification review process for medicines, vaccines and test kits, that were approved for emergency use by recognised regulatory authorities. 

The recommended test kit LabGun COVID-19 RT-PCR Kit developed by LabGenomics Co. Ltd, Republic of Korea is a real-time polymerase chain reaction test kit.  The kit is authorised for use on respiratory samples collected from individuals who are suspected of COVID-19 by their healthcare provider and is recommended for use only during the pandemic period, by authorised agencies and/or laboratory personnel.

Dr Joy St. John Executive Director of CARPHA stated “In pandemic emergency situations, national regulatory authorities must make the best decisions they can, based on available evidence of risk-benefit, which in some cases may be limited.  The application of this approach by the CRS will assist national regulatory authorities to identify products that have been assessed by trusted regulatory authorities, thereby reducing the time and resources needed to undertake local review, and enable faster access for use in CARICOM Member States.”

CARPHA-CRS has verified that the kit is the same product granted emergency authorisation by the US Food and Drug Administration (US FDA), and integrates technical aspects of CARPHA’s Guidance for the Evaluation and Selection of Diagnostic Tests for the COVID-19 Response.  

According to the technical specifications provided by the company, the kit has a sensitivity and specificity > 95%, and meets the standard ISO 13485 for medical devices.

The recommendation for use is based on the emergency use authorization (EUA) issued by the US FDA for the qualitative detection of nucleic acid from SARS-CoV-2 in nasopharyngeal, or oropharyngeal, anterior nasal and mid-turbinate nasal swabs, as well as nasopharyngeal wash/aspirate or nasal aspirate specimens and sputum.

Additional information about the CARPHA CRS can be found here.  Information on the technical requirements for the EUA review procedure by the CRS may be found at:  https://carpha.org/What-We-Do/CRS/Operational-Policy.  The CRS team may be reached at CRSRegistration@carpha.org.

 

###

 

 

Tags

Categories

News, New at CARPHA

Share

Rating

0 ( 0 reviews)

Post a Comment

  • Recent
  • Popular
  • Tag
  • CARPHA Encourages Persons to Know their Blood Pressure

    Port-of-Spain, Trinidad and Tobago, May 16, 2014: The Caribbean Public Health Agency (CARPHA) is calling on persons to know their blood pressure, strive to keep it healthy or lower it. This is in keep...
  • CARPHA and CTO Launch Tourism and Health Programme

    CARPHA and CTO successfully launched the regional tourism and health programme and conducted an awareness and discussion workshop on Friday May 2, 2014 in Aruba. The keynote address was given by the M...
  • CARPHA’s new Chairman of the Board

    Port-of-Spain, Trinidad and Tobago, October 02, 2013: The Caribbean Public Health Agency (CARPHA) is pleased to announce the appointment of the Honourable Colin Riley, Minister of Health of Montserrat...
  • Saint Lucia Joins Regional Project to Build Public Health Capacity

    Castries, Saint Lucia, September 04, 2014. The Ministry of Health, Wellness, Human Services and Gender Relations, in collaboration with the Caribbean Public Health Agency (CARPHA), is launching the Ca...
  • New CARPHA lab to help region respond to health threats

    The Caribbean Public Health Agency (CARPHA) moved today one step forward in its mission to provide strategic direction in analyzing, defining and responding to public health priorities of CARICOM, in ...
  • GRANT WRITING WORKSHOP

    The Center for Global Health of the National Cancer Institute (NCI), National Institutes of Health (NIH) in the U.S., in collaboration with the Caribbean Public Health Agency (CARPHA), St. George's Un...
  • CR-FELTP Trains New Mentors in Jamaica

    Caribbean Regional Field Epidemiology and Laboratory Training Programme (CR-FELTP) Trains New Mentors in Jamaica The Caribbean Public Health Agency (CARPHA) hosted a four-day workshop in Kingston, Jam...
  • Risk of Ebola in the Caribbean "Low"

    Port-of-Spain, Trinidad and Tobago, August 06, 2014: The Caribbean Public Health Agency (CARPHA) says the risk of the Ebola Virus Disease (EVD) being imported to the Caribbean is low. Executive Direct...
  • Risk Communication Training to Help Senior Health Officials Better Manage Health Threats

    Risk Communication Training to Help Senior Health Officials Better Manage Health Threats Providenciales, Turks and Caicos, June 19, 2016: "Risk communication is an important tool in managing health th...
  • Influenza Activity in the Caribbean

    Port of Spain, Trinidad and Tobago, September 26, 2013. The Caribbean, like other regions in the Americas, experiences seasonal influenza activity. Improved health monitoring by Ministries of Health i...